FidoCure®

As National Veterinary Technician Week (October 13-19) approaches, FidoCure is excited to honor the invaluable role of veterinary technicians in the fight against cancer. Vet techs are true partners in care, providing support on both ends of the leash—offering expert care to dogs and emotional guidance to families navigating the cancer journey. We are incredibly grateful for their dedication and partnership as we continue our mission, having already helped over 5,000 dogs with cutting-edge, AI-driven precision medicine to receive advanced cancer care. Their compassion and expertise are essential to the progress we make every day. To celebrate, we invite you to nominate an outstanding veterinary technician who goes above and beyond in their role. They’ll have the chance to win: ✨ (1) Lunch for your team ($400 value) ✨ (1) $100 FIGS gift card ✨ (5) Personalized bandage scissors ✨ (10) $25 VISA gift card Let’s come together to recognize these professionals who are making a significant difference in the fight against pet cancer. Nominate your vet tech—or, if you're a vet tech, feel free to nominate yourself—by October 10th. Winners will be announced during Vet Tech Week! Submit your nomination today: https://hubs.li/Q02RStqc0 #FidoCure #VetTechWeek #VetTech #VetMed #DogsWithCancer #CancerCare #PetOncology

FidoCure is proud to see CEO Christina Lopes featured in the Columbia Women's Business Society newsletter, The Scope! 🎓🐾 Christina Lopes shared insights into how FidoCure is leading the charge in veterinary oncology. As pioneers in canine precision medicine, FidoCure is leveraging AI and genomic sequencing to revolutionize cancer treatment for dogs. Key highlights from the feature include: - Our AI-driven approach has expanded to over 1,350 veterinary clinics worldwide - We've built the world's largest canine cancer dataset with over 2 billion data points - Our research is accelerating drug development for both canine and human cancers - We've recently won a patent for a novel AI-developed drug to fight canine cancer Read the full profile here: https://hubs.li/Q02QCsTP0 #VeterinaryOncology #PrecisionMedicine #AIinHealthcare #CanineCancer #WomenInSTEM

Thrive Pet Healthcare and FidoCure® are celebrating two years of groundbreaking collaboration, transforming canine cancer care through innovative precision medicine. This powerful partnership has already made a significant impact, with Thrive veterinarians utilizing FidoCure's cutting-edge AI-driven platform to treat approximately 400 canine cancer cases. The results are truly inspiring, offering new hope to countless pets and their families. Venya, a 13½-year-old German Shepherd, is one of those patients. She is our inspiration to push the boundaries of veterinary oncology as she thrives despite multiple cancer diagnoses. By combining FidoCure's advanced technology with Thrive's extensive network, we're not just changing lives - we're revolutionizing the future of veterinary oncology and contributing valuable insights to human cancer research. Here's to two years of progress and to the countless breakthroughs yet to come! https://lnkd.in/gZ67Wzrn #FidoCure #VeterinaryInnovation #CanineCancerCare #PrecisionMedicine #Dogs #CancerCare

FidoCure is proud to announce our recent participation in the prestigious Kansas City Animal Health Corridor Summit, where CEO Christina Lopes unveiled the world's first portfolio of de-risked canine cancer therapies. This groundbreaking presentation marks a significant milestone in our mission to revolutionize cancer care for dogs. We are honored to have been among the leading innovators in animal healthcare, showcasing our advancements alongside other cutting-edge companies pushing the boundaries of veterinary medicine. The summit was also an incredible opportunity to announce that FidoCure is expanding into drug development. This expansion will allow us to accelerate the development of more effective and accessible cancer treatments for dogs, bringing hope to countless families facing canine cancer. #VeterinaryMedicine #CanineCancer #AnimalHealth #Innovation #DrugDevelopment

We are so proud of our founder Christina Lopes for sharing her startup journey with BayBrazil at Coursera HQ. An impressive panel of industry leaders sharing their insights and experiences as Brazilian founders in Silicon Valley. #FidoCure #BrazilBay

We're excited to share that our Founder and CEO, Christina Lopes was recently featured in Forbes! In this interview, Christina discusses her journey in building FidoCure and how the company provides cutting-edge targeted therapies to dogs, from humans. As Christina explains, dogs naturally develop many of the same cancers as humans, but their smaller size and faster disease progression allow researchers to study the full cancer journey. By first focusing on developing cutting-edge cancer treatments for our canine companions, the FidoCure team is helping thousands of dogs battling cancer. And in the process, they are uncovering insights that could profoundly impact the fight against human cancer as well. Check out the full Forbes feature to learn more about Christina's vision for FidoCure and the potential of comparative oncology: https://hubs.li/Q02M70PK0 #FidoCure #CancerResearch #Dogs #ForbesFeature

FidoCure's CEO Christina Lopes to showcase canine cancer breakthroughs at the KC Animal Health Corridor Summit! Our CEO, Christina Lopes, has been handpicked to present FidoCure's innovative approach to canine cancer treatment at the prestigious Animal Health Corridor Summit 2024 in Kansas City! This elite event spotlights the most prestigious research and medical companies in animal health, nutrition, diagnostics, and technology. It's a prime opportunity to connect with industry leaders and potential investors who can help us reach new heights in veterinary oncology. The Summit's pedigree speaks for itself: - Presenting companies have raised over $500 million - Many have secured licensing agreements, distribution contracts, or been acquired We're honored to be among the select few chosen to share our vision for the future of personalized medicine in veterinary oncology. Stay tuned as we prepare to unleash FidoCure's groundbreaking work next Monday in Kansas City! #CanineCancer #VeterinaryOncology #AnimalHealth #Innovation #FidoCure #PersonalizedMedicine #AnimalHealthCorridor

We are Rewriting the Future of Canine Cancer Care with our Newest USPTO Patent. We at FidoCure® are thrilled to share this next step in our fight against cancer. We've been granted a groundbreaking patent for an AI-driven approach that could transform how we care for dogs with cancer, particularly those battling bladder cancer. Every year, millions of families face the heartbreaking news of a cancer diagnosis for their beloved dogs. As veterinarians, you've been on the front lines, working tirelessly to provide the best care possible. Our new patented approach aims to give you more effective tools in this battle. It's not just a step forward; it's a leap into the future of precision medicine. By leveraging AI and real-world evidence from our network of 1,350 veterinary clinics, we're paving the way for more targeted treatments and this patent is just the beginning. We're committed to continuing our research and innovation with 8 more patents pending. To the veterinarians who dedicate their lives to animal health: thank you. Your expertise and compassion drive us forward. Together, we're opening new doors in canine cancer care, bringing renewed hope to countless families and their furry loved ones. https://hubs.li/Q02LjR1Z0 #CanineCancerCare #VeterinaryMedicine #PrecisionMedicine #FidoCure #Patented #USPTO

Our Founder and CEO Christina Lopes at the Nasdaq and Forbes studios yesterday talking about the lasting impact of FidoCure's work in canine cancer. Keep an eye out for more posts from us when the interview drops next month! Very proud of Christina for all her hard work in shining a light on FidoCure's mission to treat cancer on both ends of the leash 🐶

Congratulations to all of the nominees from the #WomeninAI awards last week! We are so proud to see our CEO and Founder Christina Lopes set a new precedent in veterinary oncology by being recognized for our work with AI. This wouldn't be possible without our partner James Zou at Stanford AI Health. Thank you to VentureBeat for having her! #VentureBeat #WomenInAI #VBTransform #AIinHealthcare #FidoCure